Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Business & Wealth
Market Voices
Sholanke Dele
Sholanke Dele

Waystar partners with AnMed for $6.32 million revenue gain while stock edges lower

Waystar partners with AnMed for $6.32 million revenue gain while stock edges lower
Waystar stock edges lower to $25.53

Waystar highlighted a major client win as AnMed collected $6.32 million in additional payments and a 4:1 ROI through revenue management solutions. Shares edge lower on the day, trading at $25.53.

Highlights

  • AnMed secured $6.32 million in additional payments with a 4:1 ROI by implementing Waystar revenue management solutions.
  • Waystar stock trades at $25.53, with a market value near $4.57 billion and trailing revenue of $1.2 billion.
  • 91 of 95 analysts rate Waystar stock a buy, with a median price target of $33 and none at sell.

Waystar reported that AnMed partnered with the company to bolster revenue integrity across its health system. By utilizing Waystar solutions, AnMed was able to collect $6.32 million in additional payments. The partnership also resulted in a 4:1 return on investment for AnMed through the use of DRG Anomaly Detection.

Muted daily pullback as price holds above key moving averages

Price broke under the prior weekly low at $25.7 and is now setting a new low for the week. Despite this development, the overall daily structure remains bullish as shares of Waystar hold above their MA-20, MA-50, and MA-200 levels. The daily move has been muted and runs against the broader bullish chart setup.

Upside bias for the week as traders watch $25.7 reclaim

Traders should monitor whether price can reclaim the $25.7 level to gauge if the recent event is being priced in. Shares recently moved below that weekly low and are now trading at a new low for the week. Even so, after a contained move within a narrow range over the past week, the probability of upside for the coming trading week is 64%, while the probability of downside is 36%, with an expected trading range of $24.87 to $26.18. A close above $25.7 would indicate buyer follow-through, while a drop below $25.19 would suggest the move is being faded. On the weekly chart the longer-term picture stays constructive.

Previously it was reported that Waystar was showcasing its AI-driven healthcare revenue management solutions at industry events to highlight their potential for boosting productivity and reducing claim denials. The recent client outcome with AnMed strengthens this narrative and, given the current price behavior, traders should monitor whether support holds near the lower end of the projected $24.87–$26.18 trading range for indications of a reversal or continued weakness.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Tokens without buyers: Why NFT marketplaces are shutting down
  • By Mikhail Vnuchkov
  • 9 hours ago
Tokens without buyers: Why NFT marketplaces are shutting down
Editors' Picks
Is it bad to be rich: Why billionaires are seen as villains
  • By Alena Volkova
  • 12 hours ago
Is it bad to be rich: Why billionaires are seen as villains
Editors' Picks
What is a national blockchain network and does the world need one?
  • By Olena Litvinenko
  • Yesterday
What is a national blockchain network and does the world need one?
Editors' Picks
All Editors' Top Picks

Latest Waystar News

Waystar Early Adopter Program drives 86.5 percent recoupment match for Respiratory Technologies
  • By Eugene Komchuk
  • 05.10.2026
Waystar Early Adopter Program drives 86.5 percent recoupment match for Respiratory Technologies
Companies
#Waystar
Waystar reports 80 percent time savings for US Renal Care in recoupment management
  • By Eugene Komchuk
  • 02.10.2026
Waystar reports 80 percent time savings for US Renal Care in recoupment management
Companies
#Waystar
Waystar enables Deaconess Health System to generate 13.3 million dollars and cut observation rates by 3.8 percent
  • By Yulia Slavina
  • 23.09.2026
Waystar enables Deaconess Health System to generate 13.3 million dollars and cut observation rates by 3.8 percent
Companies
#Waystar
All Waystar News
  • Mikhail Vnuchkov
  • 9 hours ago
Tokens without buyers: Why NFT marketplaces are shutting down
  • Alena Volkova
  • 12 hours ago
Is it bad to be rich: Why billionaires are seen as villains
  • Olena Litvinenko
  • Yesterday
What is a national blockchain network and does the world need one?
  • Eugene Komchuk
  • Yesterday
CertiK expert: Hackers are winning the arms race for now
  • Dmytro Kharkov
  • Yesterday
Ledger’s spy chip scandal: Can hardware wallets still guard crypto’s cold storage?
  • Eugene Komchuk
  • 19 min ago
AMD acquires World Labs in $8.2 billion deal, Maya Bakhai notes
  • Pavlo Kot
  • 19 min ago
Protect what matters most by securing important documents, Suze Orman advises
  • Yulia Slavina
  • 19 min ago
Ki Young Ju: Large BTC-backed loans rise as whales borrow to buy more crypto
  • Hanna Syniavska
  • 34 min ago
Alex Bosworth: Recent BTC hacks may become easier to trace as tracking tools improve
  • Pavlo Kot
  • 50 min ago
DOJ probes California winery tied to Ilhan Omar’s husband, Benny Johnson notes
Top News
  • Eugene Komchuk
  • 6 hours ago
Paul Tudor Jones predicts a challenging 2027 for stock market
Paul Tudor Jones predicts a challenging 2027 for stock market
  • Ivan Andriyenko
  • 6 hours ago
Brent falls below $105 despite rising tensions in the Gulf
Brent falls below $105 despite rising tensions in the Gulf
  • Igor Krasulya
  • 9 hours ago
Cathie Wood warns of risks in memory chip stocks
Cathie Wood warns of risks in memory chip stocks
  • Olga Shendetskaya
  • 12 hours ago
Gold prices rise as Middle East tensions complicate Fed rate outlook
Gold prices rise as Middle East tensions complicate Fed rate outlook
  • Olga Shendetskaya
  • 13 hours ago
Asian tech shares fall sharply as doubts grow over AI profits
Asian tech shares fall sharply as doubts grow over AI profits
Live News
  • Johnathan Maverick
  • Now
Interactive Brokers launches Ethereum staking for clients through zerohash
  • Olga Shendetskaya
  • Now
Barclays looks to reenter India equity capital markets
  • Mykhailo Ihnatenko
  • Now
Nvidia stock tests key support as China competition intensifies
  • Ivan Andriyenko
  • Now
U.S. stock futures mixed as chip stocks extend losses
  • Anton Kharitonov
  • Now
EUR/USD remains under pressure as dollar strength and European risks weigh on the euro
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers